Ethan Michael Weinberg

Ethan Weinberg practices at Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania, part of University of Pennsylvania.

Ethan Weinberg's NPI, 1760625487, was assigned on April 10, 2009. Ethan Weinberg graduated from University of Maryland School of Medicine in 2009. Ethan Weinberg holds Pennsylvania license MD457568.

Ethan Weinberg's primary practice is Hospital of the University of Pennsylvania, at 3400 Spruce St, Philadelphia, PA 19104 in Philadelphia County. The practice phone is (215) 662-6289.

Ethan Weinberg's primary practice is Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania, part of University of Pennsylvania. Ethan Weinberg is also affiliated with Penn Presbyterian Medical Center. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Ethan Weinberg to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Ethan Weinberg practices, 5 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Ethan Weinberg's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Ethan Weinberg is licensed in Pennsylvania.

CMS data shows 473 Medicare services from Ethan Weinberg across 9 procedure codes in 2024, for 202 Medicare patients. Medicare paid $24,304 for them.

CMS counts 202 Medicare patients who saw Ethan Weinberg in 2024. The largest group is 65 to 74, with 121 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 14% are also on Medicaid. Their average risk score is 2.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Ethan Weinberg's median patient age at 61, with 47% women.

In 2024, Ethan Weinberg wrote 837 Medicare Part D claims for 156 patients. 85% of them were for generic drugs. CMS names the drug for 643 of them, across 21 drugs with 11 or more claims each, at $584,810 in total drug cost. In 2023, CMS named 576 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Ethan Weinberg for performance year 2024, reported as part of a group. Ethan Weinberg accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Ethan Weinberg as offering telehealth. CMS counts 35 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Ethan Weinberg, more than 58% of the clinicians it reports for that procedure.

Dmand AI links 44 papers to Ethan Weinberg, published from 2010 to 2025. 2023 was the busiest year, with 8. The most frequent topics are Liver Transplantation, Liver Cirrhosis and Liver Neoplasms. Ethan Weinberg has published most often in Liver Transpl. Ethan Weinberg's most frequent co-authors are Marina Serper, MD, Robert M. Weinrieb, MD and Richard Todd Frederick, MD.

Dmand AI links Ethan Weinberg to 4 clinical trials, 3 of them phase 2 studies. Conditions studied include Ascites, Hepatorenal Syndrome and Liver Cirrhosis, Biliary.

CMS Open Payments shows 47 general payments to Ethan Weinberg from 12 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 85% of the total. Novo Nordisk Inc paid the most, $12,103. It also lists 5 research payments totaling $3,978 from 2016 to 2025.

Ethan Weinberg graduated from University of Maryland School of Medicine in 2009.